Company intelligence / Profile preview

MatOrtho

Leatherhead, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

MatOrtho’s key products, including the SAIPH Knee System and ADEPT Hip Resurfacing System, have demonstrated excellent clinical outcomes, such as over 95% patient satisfaction and a revision rate of just 0.3% at three years for the ReCerf Hip Resurfacing System according to registry data. ReCerf, the world's first all-ceramic hip resurfacing, is regulatory approved in Australia and Europe, with more than 1,200 patients treated and exceptional outcomes for both younger and active patients[3][1][4].

Therapeutic areas: OtherRheumatology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on MatOrtho.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MatOrtho.

Explore the full profile